Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arntl
|
ENSMUSG00000055116.7 | aryl hydrocarbon receptor nuclear translocator-like |
Tfe3
|
ENSMUSG00000000134.11 | transcription factor E3 |
Mlx
|
ENSMUSG00000017801.9 | MAX-like protein X |
Mitf
|
ENSMUSG00000035158.9 | melanogenesis associated transcription factor |
Mlxipl
|
ENSMUSG00000005373.7 | MLX interacting protein-like |
Tfec
|
ENSMUSG00000029553.7 | transcription factor EC |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_113206679_113207162 | Arntl | 545 | 0.805445 | -0.61 | 2.5e-07 | Click! |
chr7_113207462_113208685 | Arntl | 516 | 0.819979 | -0.49 | 6.3e-05 | Click! |
chr7_113193185_113193336 | Arntl | 14205 | 0.203597 | -0.16 | 2.3e-01 | Click! |
chr7_113197443_113197637 | Arntl | 9925 | 0.215341 | 0.15 | 2.6e-01 | Click! |
chr7_113251552_113251704 | Arntl | 11874 | 0.195592 | -0.13 | 3.2e-01 | Click! |
chr6_97807057_97807712 | Mitf | 326 | 0.904395 | -0.61 | 1.9e-07 | Click! |
chr6_97806453_97806860 | Mitf | 396 | 0.872578 | -0.38 | 2.6e-03 | Click! |
chr6_97938208_97938822 | Mitf | 2403 | 0.378483 | -0.33 | 9.9e-03 | Click! |
chr6_97829579_97829759 | Mitf | 22611 | 0.193304 | 0.31 | 1.6e-02 | Click! |
chr6_97941578_97941729 | Mitf | 735 | 0.757301 | -0.29 | 2.7e-02 | Click! |
chr11_101086944_101087265 | Mlx | 173 | 0.871912 | -0.47 | 1.3e-04 | Click! |
chr11_101089889_101090040 | Mlx | 302 | 0.762313 | -0.23 | 8.1e-02 | Click! |
chr11_101087291_101087958 | Mlx | 320 | 0.745153 | -0.21 | 1.1e-01 | Click! |
chr11_101091829_101091980 | Mlx | 2242 | 0.124962 | 0.19 | 1.4e-01 | Click! |
chr11_101086231_101086382 | Mlx | 971 | 0.302496 | -0.17 | 2.0e-01 | Click! |
chr5_135106615_135106867 | Mlxipl | 150 | 0.912119 | -0.55 | 6.1e-06 | Click! |
chr5_135106899_135107723 | Mlxipl | 393 | 0.731320 | -0.50 | 4.4e-05 | Click! |
chr5_135133585_135134181 | Mlxipl | 252 | 0.852500 | -0.45 | 2.9e-04 | Click! |
chr5_135108672_135108925 | Mlxipl | 1880 | 0.190113 | 0.31 | 1.7e-02 | Click! |
chr5_135089349_135090341 | Mlxipl | 45 | 0.945857 | -0.25 | 5.0e-02 | Click! |
chrX_7769331_7769799 | Tfe3 | 135 | 0.902431 | 0.50 | 4.8e-05 | Click! |
chrX_7779134_7779411 | Tfe3 | 9842 | 0.079090 | 0.46 | 2.6e-04 | Click! |
chrX_7762094_7762416 | Tfe3 | 305 | 0.763566 | -0.29 | 2.3e-02 | Click! |
chrX_7764730_7766125 | Tfe3 | 775 | 0.402379 | -0.24 | 6.1e-02 | Click! |
chrX_7762615_7764205 | Tfe3 | 533 | 0.560194 | -0.23 | 8.2e-02 | Click! |
chr6_16896833_16897427 | Tfec | 1269 | 0.532674 | 0.45 | 3.2e-04 | Click! |
chr6_16895712_16895863 | Tfec | 2612 | 0.335943 | 0.31 | 1.8e-02 | Click! |
chr6_16898104_16898641 | Tfec | 27 | 0.983256 | 0.30 | 2.0e-02 | Click! |
chr6_16854844_16855260 | Tfec | 9056 | 0.258930 | -0.13 | 3.1e-01 | Click! |
chr6_16855292_16855468 | Tfec | 9384 | 0.257751 | -0.10 | 4.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_41072966_41074089 | 13.33 |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
5979 |
0.19 |
chr11_96343236_96346574 | 10.76 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr7_5029343_5032174 | 9.28 |
Zfp865 |
zinc finger protein 865 |
1434 |
0.15 |
chr14_70625458_70627688 | 8.92 |
Dmtn |
dematin actin binding protein |
418 |
0.75 |
chr11_120114354_120114891 | 8.56 |
Slc38a10 |
solute carrier family 38, member 10 |
4164 |
0.12 |
chr11_117779316_117780928 | 8.55 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr19_45230983_45235468 | 8.10 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr2_121035039_121035972 | 8.07 |
Epb42 |
erythrocyte membrane protein band 4.2 |
1176 |
0.33 |
chr7_120969565_120970006 | 7.91 |
Cdr2 |
cerebellar degeneration-related 2 |
12005 |
0.1 |
chr9_44340460_44342952 | 7.66 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr11_117781898_117782456 | 7.51 |
Tmc6 |
transmembrane channel-like gene family 6 |
21 |
0.57 |
chr8_84741754_84745977 | 7.37 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
20858 |
0.09 |
chr5_24426725_24429282 | 7.34 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
205 |
0.83 |
chr8_39152857_39153347 | 7.32 |
Gm20948 |
predicted gene, 20948 |
47947 |
0.13 |
chr15_103013757_103015908 | 7.07 |
Mir615 |
microRNA 615 |
78 |
0.91 |
chr14_76532606_76533942 | 7.00 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr1_132366786_132367836 | 6.95 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
239 |
0.89 |
chr2_25577192_25580600 | 6.81 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr7_120879515_120880256 | 6.78 |
Eef2k |
eukaryotic elongation factor-2 kinase |
3665 |
0.15 |
chr5_108674592_108675616 | 6.63 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
319 |
0.8 |
chr8_77534358_77534604 | 6.62 |
Prmt9 |
protein arginine methyltransferase 9 |
14916 |
0.13 |
chr17_71267820_71268552 | 6.61 |
Emilin2 |
elastin microfibril interfacer 2 |
411 |
0.81 |
chr7_100465236_100467118 | 6.57 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr8_84722866_84724458 | 6.57 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
655 |
0.54 |
chr8_120292266_120293650 | 6.51 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr4_62514007_62514398 | 6.38 |
Alad |
aminolevulinate, delta-, dehydratase |
5679 |
0.12 |
chr11_32286728_32287865 | 6.37 |
Hbq1b |
hemoglobin, theta 1B |
295 |
0.81 |
chr7_133114831_133116529 | 6.34 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr6_143832506_143833713 | 6.33 |
Sox5 |
SRY (sex determining region Y)-box 5 |
113979 |
0.06 |
chr6_86078066_86079298 | 6.16 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr8_124569006_124569716 | 6.06 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
345 |
0.86 |
chr3_30766023_30766403 | 6.01 |
Samd7 |
sterile alpha motif domain containing 7 |
9991 |
0.14 |
chr11_102360845_102363484 | 5.98 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr15_12193885_12195324 | 5.94 |
Gm49240 |
predicted gene, 49240 |
2015 |
0.19 |
chr11_83281871_83282887 | 5.88 |
Slfn14 |
schlafen 14 |
4347 |
0.1 |
chr14_79298239_79299672 | 5.83 |
Rgcc |
regulator of cell cycle |
2690 |
0.24 |
chr7_100492685_100494805 | 5.78 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr2_173024069_173026002 | 5.77 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr17_48300015_48301474 | 5.69 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr2_119872284_119873653 | 5.59 |
Gm13998 |
predicted gene 13998 |
5435 |
0.17 |
chr11_77892631_77894065 | 5.54 |
Pipox |
pipecolic acid oxidase |
748 |
0.58 |
chr14_118796451_118797209 | 5.50 |
Cldn10 |
claudin 10 |
8912 |
0.16 |
chr1_161750875_161751601 | 5.43 |
Gm5049 |
predicted gene 5049 |
5182 |
0.16 |
chr11_115903315_115904189 | 5.39 |
Recql5 |
RecQ protein-like 5 |
3501 |
0.11 |
chr3_84477728_84478854 | 5.34 |
Fhdc1 |
FH2 domain containing 1 |
691 |
0.74 |
chr2_173026008_173027110 | 5.32 |
Rbm38 |
RNA binding motif protein 38 |
3509 |
0.16 |
chr4_154911979_154912466 | 5.31 |
Prxl2b |
peroxiredoxin like 2B |
13087 |
0.11 |
chr11_102364387_102365146 | 5.31 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr17_48448887_48449311 | 5.30 |
Tspo2 |
translocator protein 2 |
971 |
0.43 |
chr11_31824541_31824785 | 5.28 |
D630024D03Rik |
RIKEN cDNA D630024D03 gene |
139 |
0.96 |
chr8_83215299_83216454 | 5.23 |
Tbc1d9 |
TBC1 domain family, member 9 |
43383 |
0.11 |
chr10_61544232_61544740 | 5.18 |
Gm47594 |
predicted gene, 47594 |
26425 |
0.1 |
chr16_30387562_30389582 | 5.18 |
Atp13a3 |
ATPase type 13A3 |
42 |
0.98 |
chr14_76531223_76531863 | 5.15 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
4927 |
0.22 |
chr6_52202371_52204739 | 5.12 |
Hoxa5 |
homeobox A5 |
1032 |
0.2 |
chr16_96442343_96442648 | 5.08 |
Itgb2l |
integrin beta 2-like |
1117 |
0.43 |
chr10_67297290_67297848 | 5.02 |
Gm49454 |
predicted gene, 49454 |
163 |
0.95 |
chr13_45513570_45514179 | 5.00 |
Gmpr |
guanosine monophosphate reductase |
34 |
0.98 |
chr14_52196647_52197712 | 4.99 |
Supt16 |
SPT16, facilitates chromatin remodeling subunit |
237 |
0.56 |
chr10_80856664_80858456 | 4.96 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr17_31208121_31208604 | 4.94 |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
271 |
0.86 |
chr9_48336275_48336541 | 4.93 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
4426 |
0.24 |
chr15_73176794_73178055 | 4.92 |
Ago2 |
argonaute RISC catalytic subunit 2 |
423 |
0.85 |
chr5_115946520_115947438 | 4.90 |
Cit |
citron |
1682 |
0.33 |
chr10_79706079_79708046 | 4.78 |
Bsg |
basigin |
2492 |
0.11 |
chr12_3930259_3930780 | 4.68 |
Gm9088 |
predicted gene 9088 |
1521 |
0.33 |
chr5_115542473_115545179 | 4.66 |
Pxn |
paxillin |
121 |
0.92 |
chr5_125056018_125058841 | 4.65 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr9_48338929_48340200 | 4.63 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr11_75165245_75169157 | 4.59 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr2_84735706_84738103 | 4.57 |
Ypel4 |
yippee like 4 |
2677 |
0.11 |
chr4_104766381_104766876 | 4.54 |
C8b |
complement component 8, beta polypeptide |
233 |
0.96 |
chr12_77216587_77217064 | 4.53 |
Fut8 |
fucosyltransferase 8 |
21300 |
0.19 |
chr11_61683750_61685180 | 4.52 |
Fam83g |
family with sequence similarity 83, member G |
46 |
0.97 |
chr2_32078207_32079756 | 4.51 |
Fam78a |
family with sequence similarity 78, member A |
371 |
0.77 |
chr6_122390680_122391030 | 4.45 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
524 |
0.69 |
chr17_71001223_71003092 | 4.44 |
Myl12a |
myosin, light chain 12A, regulatory, non-sarcomeric |
3 |
0.49 |
chr5_139737935_139738668 | 4.44 |
Micall2 |
MICAL-like 2 |
1965 |
0.25 |
chr10_81406559_81408241 | 4.44 |
Nfic |
nuclear factor I/C |
241 |
0.76 |
chr11_58918085_58918881 | 4.38 |
Btnl10 |
butyrophilin-like 10 |
426 |
0.61 |
chr8_104962508_104963341 | 4.37 |
Ces2g |
carboxylesterase 2G |
1149 |
0.31 |
chr16_77236731_77239778 | 4.35 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1935 |
0.4 |
chr4_6413307_6414195 | 4.34 |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
10237 |
0.18 |
chr11_96318060_96319501 | 4.33 |
Hoxb4 |
homeobox B4 |
513 |
0.51 |
chr12_103656349_103656500 | 4.31 |
Serpina6 |
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
678 |
0.54 |
chr13_58522751_58523890 | 4.30 |
Gm3131 |
predicted gene 3131 |
22708 |
0.16 |
chr3_34648572_34651394 | 4.29 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr13_103773546_103774846 | 4.29 |
Srek1 |
splicing regulatory glutamine/lysine-rich protein 1 |
103 |
0.98 |
chr14_121145029_121145811 | 4.27 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
43341 |
0.18 |
chr7_45523041_45524800 | 4.25 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr2_70564530_70567543 | 4.24 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr8_25542987_25545804 | 4.24 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr8_94986231_94987228 | 4.23 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1161 |
0.36 |
chr3_132629876_132630281 | 4.20 |
Gimd1 |
GIMAP family P-loop NTPase domain containing 1 |
63 |
0.97 |
chr12_91745342_91746056 | 4.15 |
Ston2 |
stonin 2 |
385 |
0.85 |
chr15_77753662_77753974 | 4.12 |
Apol8 |
apolipoprotein L 8 |
1421 |
0.26 |
chr7_100494865_100496416 | 4.10 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr6_18435045_18435488 | 4.10 |
Cttnbp2 |
cortactin binding protein 2 |
815 |
0.56 |
chr2_157026864_157027931 | 4.07 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
75 |
0.96 |
chr2_9882196_9886301 | 4.06 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr2_173061868_173062132 | 4.04 |
Gm14453 |
predicted gene 14453 |
27420 |
0.12 |
chr2_105125289_105128976 | 4.03 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr11_90726819_90728183 | 4.03 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39135 |
0.15 |
chr4_87804582_87805116 | 4.02 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
1445 |
0.57 |
chr18_32557788_32558922 | 4.01 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr5_34975144_34975655 | 4.01 |
Rgs12 |
regulator of G-protein signaling 12 |
407 |
0.83 |
chr12_103656514_103657055 | 3.99 |
Serpina6 |
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
318 |
0.81 |
chr2_181206070_181206364 | 3.97 |
Ptk6 |
PTK6 protein tyrosine kinase 6 |
3428 |
0.11 |
chr11_33202043_33204837 | 3.96 |
Tlx3 |
T cell leukemia, homeobox 3 |
149 |
0.86 |
chr1_38128773_38130359 | 3.95 |
Rev1 |
REV1, DNA directed polymerase |
96 |
0.96 |
chrX_9256153_9256810 | 3.94 |
Gm14862 |
predicted gene 14862 |
418 |
0.78 |
chr17_40813775_40814352 | 3.92 |
Rhag |
Rhesus blood group-associated A glycoprotein |
2879 |
0.21 |
chr11_83285353_83286025 | 3.92 |
Slfn14 |
schlafen 14 |
1037 |
0.31 |
chr18_82567966_82568510 | 3.91 |
Mbp |
myelin basic protein |
4976 |
0.19 |
chr6_146220162_146220523 | 3.91 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
7201 |
0.26 |
chr14_41007005_41008239 | 3.91 |
Prxl2a |
peroxiredoxin like 2A |
644 |
0.68 |
chr8_80868770_80869328 | 3.91 |
Gm31105 |
predicted gene, 31105 |
10891 |
0.18 |
chrX_150547515_150548479 | 3.90 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr18_62174392_62175675 | 3.89 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr1_75217955_75219308 | 3.88 |
Tuba4a |
tubulin, alpha 4A |
7 |
0.92 |
chr7_80197844_80199539 | 3.87 |
Sema4b |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
155 |
0.91 |
chr11_69364290_69367679 | 3.85 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
1205 |
0.24 |
chr10_42581935_42584872 | 3.84 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
229 |
0.69 |
chr16_49839981_49840391 | 3.84 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15180 |
0.25 |
chr15_103250315_103251530 | 3.81 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr10_80570596_80572042 | 3.81 |
Klf16 |
Kruppel-like factor 16 |
6002 |
0.08 |
chr14_52140471_52142121 | 3.80 |
Rpgrip1 |
retinitis pigmentosa GTPase regulator interacting protein 1 |
4068 |
0.13 |
chr2_26485135_26488628 | 3.80 |
Notch1 |
notch 1 |
16383 |
0.09 |
chr6_67161907_67162479 | 3.79 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
2731 |
0.23 |
chr3_149225598_149226088 | 3.77 |
Gm10287 |
predicted gene 10287 |
98 |
0.97 |
chr2_173033564_173034786 | 3.77 |
Gm14453 |
predicted gene 14453 |
405 |
0.79 |
chr18_56926778_56927036 | 3.75 |
Marchf3 |
membrane associated ring-CH-type finger 3 |
1359 |
0.45 |
chr2_91633381_91633908 | 3.72 |
F2 |
coagulation factor II |
2751 |
0.16 |
chr15_80098310_80099146 | 3.72 |
Syngr1 |
synaptogyrin 1 |
858 |
0.41 |
chr17_31033726_31034632 | 3.71 |
Abcg1 |
ATP binding cassette subfamily G member 1 |
23496 |
0.11 |
chr11_96285767_96287533 | 3.71 |
Hoxb7 |
homeobox B7 |
27 |
0.93 |
chr11_4223643_4224101 | 3.70 |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
5647 |
0.1 |
chr5_117133717_117134877 | 3.70 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr10_81351824_81352381 | 3.69 |
Hmg20b |
high mobility group 20B |
1622 |
0.13 |
chr15_83593044_83593682 | 3.69 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
1794 |
0.26 |
chr7_25249035_25250700 | 3.69 |
Erf |
Ets2 repressor factor |
863 |
0.36 |
chr8_122697547_122698708 | 3.68 |
Gm10612 |
predicted gene 10612 |
267 |
0.75 |
chr14_66279066_66281333 | 3.67 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr17_33917893_33918974 | 3.67 |
Tapbp |
TAP binding protein |
899 |
0.21 |
chr8_84836764_84838739 | 3.63 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr11_97439854_97442222 | 3.62 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr7_30493583_30494737 | 3.62 |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
380 |
0.63 |
chr4_154635108_154637998 | 3.62 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr4_148602903_148603733 | 3.62 |
Masp2 |
mannan-binding lectin serine peptidase 2 |
743 |
0.48 |
chr17_74304492_74304643 | 3.61 |
Memo1 |
mediator of cell motility 1 |
9046 |
0.12 |
chr16_76294015_76294797 | 3.60 |
Nrip1 |
nuclear receptor interacting protein 1 |
29252 |
0.2 |
chr15_76666348_76670076 | 3.59 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr14_70624394_70624692 | 3.59 |
Dmtn |
dematin actin binding protein |
1612 |
0.25 |
chr11_32296600_32297646 | 3.57 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr11_84822134_84823653 | 3.57 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3378 |
0.15 |
chr1_131126459_131126729 | 3.57 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
11651 |
0.13 |
chr9_63144078_63146888 | 3.56 |
Skor1 |
SKI family transcriptional corepressor 1 |
1497 |
0.38 |
chr5_115531466_115532555 | 3.56 |
Pxn |
paxillin |
10904 |
0.09 |
chr5_91849602_91849753 | 3.56 |
Gm5558 |
predicted gene 5558 |
42604 |
0.1 |
chr3_83008148_83008803 | 3.56 |
Gm30097 |
predicted gene, 30097 |
13 |
0.92 |
chr6_127151640_127154010 | 3.56 |
Ccnd2 |
cyclin D2 |
632 |
0.57 |
chr8_13037819_13038703 | 3.56 |
F10 |
coagulation factor X |
423 |
0.7 |
chr10_117639919_117640430 | 3.53 |
Cpm |
carboxypeptidase M |
10674 |
0.13 |
chr8_22058063_22058754 | 3.53 |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
1611 |
0.27 |
chr2_10127975_10128560 | 3.52 |
Itih2 |
inter-alpha trypsin inhibitor, heavy chain 2 |
2396 |
0.19 |
chr7_143007094_143009025 | 3.52 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr14_75178051_75179727 | 3.51 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2681 |
0.23 |
chr7_141135204_141135424 | 3.50 |
Ptdss2 |
phosphatidylserine synthase 2 |
2761 |
0.12 |
chr11_69399334_69402458 | 3.48 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chr15_80532245_80532839 | 3.47 |
Enthd1 |
ENTH domain containing 1 |
27928 |
0.13 |
chr2_91636064_91636308 | 3.47 |
F2 |
coagulation factor II |
209 |
0.89 |
chr6_90619034_90619910 | 3.46 |
Slc41a3 |
solute carrier family 41, member 3 |
325 |
0.85 |
chr11_117800714_117801028 | 3.46 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
3211 |
0.1 |
chr3_102163154_102163727 | 3.45 |
Vangl1 |
VANGL planar cell polarity 1 |
2500 |
0.21 |
chr10_80080518_80081153 | 3.43 |
Sbno2 |
strawberry notch 2 |
5396 |
0.1 |
chr3_101354207_101354550 | 3.42 |
Igsf3 |
immunoglobulin superfamily, member 3 |
22705 |
0.13 |
chr14_55061871_55064122 | 3.42 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr6_52216788_52218128 | 3.42 |
Hoxa7 |
homeobox A7 |
6 |
0.91 |
chr8_84908331_84909758 | 3.41 |
Dnase2a |
deoxyribonuclease II alpha |
313 |
0.72 |
chr5_36726034_36726843 | 3.40 |
Gm43701 |
predicted gene 43701 |
22180 |
0.11 |
chr8_70493071_70496051 | 3.40 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr12_32060123_32061616 | 3.40 |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
280 |
0.91 |
chr9_44396453_44399065 | 3.40 |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
417 |
0.53 |
chr11_96347886_96350398 | 3.39 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr5_134913789_134913940 | 3.39 |
Cldn13 |
claudin 13 |
1662 |
0.18 |
chr9_120114964_120115764 | 3.38 |
Slc25a38 |
solute carrier family 25, member 38 |
375 |
0.69 |
chr17_88466769_88467029 | 3.38 |
Foxn2 |
forkhead box N2 |
26124 |
0.16 |
chr7_75586786_75587711 | 3.36 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
22791 |
0.17 |
chr10_86023427_86024178 | 3.36 |
A230060F14Rik |
RIKEN cDNA A230060F14 gene |
1473 |
0.24 |
chr8_94172106_94173724 | 3.36 |
Mt2 |
metallothionein 2 |
55 |
0.87 |
chr4_99655774_99658132 | 3.35 |
Foxd3 |
forkhead box D3 |
654 |
0.43 |
chr10_81060304_81060538 | 3.35 |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
240 |
0.82 |
chr5_139390751_139391547 | 3.35 |
Gpr146 |
G protein-coupled receptor 146 |
1364 |
0.29 |
chr19_55941741_55942415 | 3.35 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
43769 |
0.16 |
chr8_80495549_80496014 | 3.35 |
Gypa |
glycophorin A |
2000 |
0.38 |
chr1_132365874_132366736 | 3.33 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
767 |
0.54 |
chr19_7421074_7423945 | 3.32 |
Mir6991 |
microRNA 6991 |
64 |
0.94 |
chr2_74734325_74737080 | 3.32 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr5_137570868_137571950 | 3.31 |
Tfr2 |
transferrin receptor 2 |
42 |
0.93 |
chr5_64810297_64813272 | 3.30 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.5 | 10.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.4 | 9.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.1 | 8.5 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
2.0 | 13.9 | GO:0002576 | platelet degranulation(GO:0002576) |
2.0 | 9.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.8 | 11.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.8 | 7.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.8 | 5.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.7 | 5.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.7 | 5.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.7 | 6.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.6 | 6.2 | GO:0032264 | IMP salvage(GO:0032264) |
1.6 | 39.0 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.6 | 6.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.5 | 4.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.5 | 4.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.5 | 6.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.5 | 6.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.5 | 1.5 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
1.5 | 4.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.4 | 4.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.4 | 5.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.4 | 5.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.4 | 4.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.4 | 4.1 | GO:0061511 | centriole elongation(GO:0061511) |
1.3 | 4.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.3 | 5.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 2.6 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
1.3 | 3.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 5.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 2.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.3 | 3.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 3.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 3.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.2 | 4.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.2 | 3.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.2 | 6.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 1.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.2 | 3.6 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.2 | 2.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.2 | 2.3 | GO:0015677 | copper ion import(GO:0015677) |
1.2 | 3.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.2 | 4.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.1 | 3.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.1 | 4.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.1 | 1.1 | GO:0033363 | secretory granule organization(GO:0033363) |
1.1 | 3.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.1 | 7.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.1 | 3.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.1 | 4.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 4.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.1 | 8.5 | GO:0097286 | iron ion import(GO:0097286) |
1.0 | 4.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.0 | 5.2 | GO:0019532 | oxalate transport(GO:0019532) |
1.0 | 9.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.0 | 3.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.0 | 10.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.0 | 1.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.0 | 1.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.0 | 2.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.0 | 2.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.0 | 11.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.0 | 2.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.0 | 3.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 3.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.0 | 2.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.0 | 4.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.0 | 2.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.0 | 2.9 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.0 | 2.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.0 | 1.9 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.0 | 4.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 0.9 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.9 | 1.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.9 | 2.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.9 | 2.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.9 | 1.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.9 | 1.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 5.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 5.4 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.9 | 5.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.9 | 5.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.9 | 4.5 | GO:0036233 | glycine import(GO:0036233) |
0.9 | 4.5 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.9 | 1.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.9 | 2.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.9 | 2.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 7.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 5.2 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.9 | 6.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.9 | 2.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.9 | 2.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.8 | 3.4 | GO:0008228 | opsonization(GO:0008228) |
0.8 | 5.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.8 | 2.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 3.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.8 | 4.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 2.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.8 | 2.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.8 | 4.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.8 | 2.4 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.8 | 4.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.8 | 8.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 2.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.8 | 1.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 4.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.8 | 3.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.8 | 0.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 3.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.8 | 3.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.8 | 2.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 2.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.8 | 0.8 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.8 | 1.5 | GO:0046618 | drug export(GO:0046618) |
0.8 | 2.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.7 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 2.2 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.7 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.7 | 1.5 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.7 | 3.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.7 | 2.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 0.7 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.7 | 2.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.7 | 4.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.7 | 0.7 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.7 | 0.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 2.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.1 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.7 | 3.5 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.7 | 4.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.7 | 0.7 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.7 | 1.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 2.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 2.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 0.7 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.7 | 2.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 2.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.7 | 0.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.7 | 5.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.7 | 3.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.7 | 1.4 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 0.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 1.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 1.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 2.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 2.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 6.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.7 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.7 | 2.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.7 | 2.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 4.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 9.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.6 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 1.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 3.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 0.6 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.6 | 5.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 8.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.6 | 3.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 3.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 2.5 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.6 | 1.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 0.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 1.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 1.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 3.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.6 | 1.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.6 | 3.7 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.6 | 0.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.6 | 1.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.6 | 3.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 1.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 4.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 1.8 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.6 | 0.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 1.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.6 | 10.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.6 | 7.8 | GO:0046697 | decidualization(GO:0046697) |
0.6 | 4.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 2.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 1.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.6 | 1.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 1.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.6 | 8.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 0.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.6 | 3.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 4.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 1.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 1.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.6 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 1.7 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.6 | 1.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.6 | 6.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.6 | 2.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 2.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 0.6 | GO:0060416 | response to growth hormone(GO:0060416) |
0.6 | 5.7 | GO:0048821 | erythrocyte development(GO:0048821) |
0.6 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 9.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 0.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 3.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 1.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.6 | 1.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.6 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 3.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.5 | 3.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.5 | 4.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 2.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 2.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 3.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 2.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 3.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.5 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 9.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 4.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.5 | 0.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.5 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 1.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 1.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.5 | 0.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 2.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.5 | 2.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 1.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 1.5 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.5 | 1.5 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.5 | 4.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.5 | 2.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.5 | 2.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.5 | 2.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) deoxyribonucleoside monophosphate metabolic process(GO:0009162) pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) dUMP metabolic process(GO:0046078) |
0.5 | 6.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.5 | 8.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 3.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 6.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 0.5 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.5 | 0.5 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.5 | 1.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 2.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 1.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 1.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 1.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.5 | 1.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 5.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 1.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 0.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 1.4 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.5 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 2.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 0.9 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 0.5 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 2.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 9.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.5 | 1.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 1.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 0.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 2.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.4 | 1.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 8.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 7.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 3.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 0.4 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.4 | 1.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.4 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 1.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 0.9 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 3.5 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 0.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 3.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 0.4 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 1.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 2.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.4 | 0.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.4 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 0.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.4 | 3.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 0.8 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.4 | 1.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 2.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.7 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 1.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.4 | 0.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 2.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 1.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 1.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 2.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 2.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.4 | 1.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 1.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 6.8 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 1.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 0.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.4 | 2.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 2.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.4 | 0.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 4.0 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 4.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 2.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 0.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.4 | 1.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 2.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 1.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 0.8 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 7.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 0.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 1.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.4 | 0.7 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 2.9 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 0.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.4 | 2.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 0.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.4 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 0.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.4 | 0.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 1.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 1.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 1.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.4 | 1.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.7 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 1.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 1.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.4 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.3 | 1.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 5.9 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.3 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 0.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.3 | 0.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.0 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 1.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 1.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 1.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.0 | GO:1903286 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 2.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 1.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 1.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.7 | GO:0006568 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.3 | 0.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 1.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.3 | 1.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 2.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.7 | GO:1903659 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 0.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 2.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 4.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 1.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 0.6 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.3 | 0.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 1.3 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 1.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 1.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 1.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 2.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 0.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 3.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.9 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.3 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 2.5 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 1.9 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 1.9 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 0.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.3 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.3 | 9.3 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 1.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 2.4 | GO:0007135 | meiosis II(GO:0007135) |
0.3 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 1.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 4.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 1.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 1.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 2.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 1.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 8.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 3.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 3.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 2.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 1.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.5 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 6.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.5 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 1.7 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.3 | 1.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 2.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.6 | GO:0021546 | rhombomere development(GO:0021546) |
0.3 | 0.6 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.8 | GO:0060525 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 0.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.6 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 3.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 1.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 1.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 1.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 2.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.3 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 0.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.3 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 1.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.3 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 2.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 2.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.8 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 1.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 0.5 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.3 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.3 | 3.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.3 | 2.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 3.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 0.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 0.5 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 2.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 0.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.3 | 1.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 0.3 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.3 | 1.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 1.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 4.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 2.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 2.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 1.5 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 1.0 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 2.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.5 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.2 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 2.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.5 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 4.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.2 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.2 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 2.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.9 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.2 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 2.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.2 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 1.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 1.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.7 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.2 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 2.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 2.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 4.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 3.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 1.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 1.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 2.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.4 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 1.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.2 | 0.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 1.7 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.2 | 0.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 6.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 7.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 4.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 1.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 2.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 6.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 2.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 1.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 1.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 2.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 1.4 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 1.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.6 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 2.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 2.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.4 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 0.6 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.2 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 1.0 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.2 | 1.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.8 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 4.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.1 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.9 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 1.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 1.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.5 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 0.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.7 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.2 | 0.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 7.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 0.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 1.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.2 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 0.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.2 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.1 | GO:0090151 | protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 0.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 2.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.3 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 1.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 1.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.2 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 4.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 2.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 1.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 2.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 4.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 1.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 2.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.5 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.2 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 1.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.2 | 1.5 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.2 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.2 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 0.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.2 | GO:0060066 | oviduct development(GO:0060066) |
0.2 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 1.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 2.2 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.3 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 1.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 2.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.4 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 3.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.6 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.7 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 1.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.7 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 4.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 4.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.3 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 1.2 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.3 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 1.0 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.9 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.3 | GO:0033206 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.4 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 3.0 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.7 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.5 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.5 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.6 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.4 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 1.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 2.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.9 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.6 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.1 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.3 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 1.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.5 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.9 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.3 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.3 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.6 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.1 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.1 | 2.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 0.5 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.3 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.9 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 1.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 2.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 2.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 1.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.5 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.2 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 1.9 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.1 | 0.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.9 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 1.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 1.8 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.3 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 2.9 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 2.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.7 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.2 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 1.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 1.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 1.5 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.2 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 1.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.9 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.0 | 6.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.0 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.8 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 2.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 2.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.5 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.0 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.6 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 3.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:0070723 | response to cholesterol(GO:0070723) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.0 | 0.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 1.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.0 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.0 | 0.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.0 | 0.1 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.0 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.2 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 1.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 20.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.9 | 5.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.9 | 9.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.8 | 9.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.6 | 4.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.5 | 1.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.4 | 7.1 | GO:0005579 | membrane attack complex(GO:0005579) |
1.3 | 4.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.2 | 3.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.2 | 7.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.0 | 7.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.0 | 2.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 2.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.9 | 4.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 3.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 4.9 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.8 | 2.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 0.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.7 | 6.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 1.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 2.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 5.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.7 | 2.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 2.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 1.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 3.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 2.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.6 | 2.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 4.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 6.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 4.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 1.8 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 4.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 1.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 2.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 3.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 2.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 2.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 6.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 1.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 2.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.5 | 50.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 2.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 7.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 5.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 1.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.5 | 1.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 2.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 2.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 5.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 13.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 3.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 4.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 1.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 11.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 2.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 0.4 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 3.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 16.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 1.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 9.9 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 7.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 13.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 1.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 1.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 1.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 2.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.2 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 3.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.8 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 12.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 1.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 3.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.8 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 4.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 17.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 9.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.1 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 3.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.2 | GO:0097346 | Swr1 complex(GO:0000812) INO80-type complex(GO:0097346) |
0.2 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 5.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.3 | GO:0005818 | aster(GO:0005818) |
0.2 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 6.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 8.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 4.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 2.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 22.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 4.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 18.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 1.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 3.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.2 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 3.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 1.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 0.7 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 2.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 2.2 | GO:0071010 | prespliceosome(GO:0071010) |
0.2 | 2.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 6.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 5.2 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 2.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 2.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 9.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 6.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 6.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 6.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 2.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 3.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 1.5 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 1.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.5 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 1.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 6.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.9 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 7.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 32.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 13.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 5.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 4.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 10.1 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 2.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 5.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 6.2 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 1.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 2.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 3.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.6 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 1.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 5.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 1.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 5.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 6.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 2.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 7.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.3 | GO:0030894 | replisome(GO:0030894) |
0.1 | 2.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 48.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 10.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 32.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 2.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 9.7 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 1.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.4 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 5.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.5 | GO:1990234 | transferase complex(GO:1990234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 8.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.0 | 8.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.9 | 5.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.9 | 5.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.8 | 7.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.5 | 4.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.5 | 7.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.5 | 10.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 4.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.4 | 4.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.4 | 5.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 2.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.2 | 4.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.2 | 3.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.2 | 8.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.1 | 5.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 3.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 4.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 3.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.0 | 3.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.0 | 4.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 4.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 6.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 2.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 2.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 2.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 3.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.9 | 2.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 5.5 | GO:0043559 | insulin binding(GO:0043559) |
0.9 | 2.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 1.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.9 | 0.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.8 | 2.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 2.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 2.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 3.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 3.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 2.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.8 | 6.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.8 | 6.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 2.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 3.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 4.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 5.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.8 | 3.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.7 | 5.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 11.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.7 | 5.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 2.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 2.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 2.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 6.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 2.1 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 0.7 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.7 | 4.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 4.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 3.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 5.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.7 | 2.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 2.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 4.6 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.6 | 1.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 2.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 1.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 3.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 3.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 8.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 5.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 2.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 1.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 3.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 1.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 2.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 4.6 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.6 | 2.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 4.5 | GO:0043841 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.6 | 5.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 2.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 8.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 0.6 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.6 | 1.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 3.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 2.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 5.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 4.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 2.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 1.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 1.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 0.5 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.5 | 1.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.5 | 2.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 3.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 2.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 4.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 3.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 7.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 12.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 6.9 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 4.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 4.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 3.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 1.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 1.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 2.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 1.4 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 26.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 0.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 1.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.5 | 13.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 3.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 2.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 3.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 0.9 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 1.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 9.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 1.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 3.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 0.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 2.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 2.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 3.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 2.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 10.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 1.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 3.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 6.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 2.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 3.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.4 | 3.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 0.8 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.4 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 1.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 3.0 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 3.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 2.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 4.0 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 2.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 8.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 2.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 1.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 2.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 3.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 5.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.0 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 5.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 1.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 3.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 2.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 1.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 3.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 2.2 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 1.3 | GO:0032564 | dATP binding(GO:0032564) |
0.3 | 0.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 1.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 1.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 2.2 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 0.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 0.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 2.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.3 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 0.9 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 11.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 3.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 2.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 2.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 3.1 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 0.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 4.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 3.1 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.1 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 7.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 1.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 1.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 2.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 30.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 0.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 3.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 2.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 3.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 5.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 4.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 4.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 2.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 4.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 2.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 1.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 4.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 6.0 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 2.1 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 2.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 2.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 2.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 6.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.8 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 6.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.8 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.2 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 4.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 3.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 1.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 2.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 3.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 7.0 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.3 | GO:0048256 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.2 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 2.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 8.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 3.2 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.2 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 8.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.9 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 3.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 5.1 | GO:0010296 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 2.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 2.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 11.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 3.8 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 2.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.8 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.2 | GO:0047419 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 3.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 2.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.9 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 1.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 25.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 1.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.9 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 3.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 16.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 8.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 20.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 1.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 10.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 2.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 2.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0089720 | death effector domain binding(GO:0035877) caspase binding(GO:0089720) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 6.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 5.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.3 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 2.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 4.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 5.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.8 | GO:0005222 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 1.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 5.6 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 10.9 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 3.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.9 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 4.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 1.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.8 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 1.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 1.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.8 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.7 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 1.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 2.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 4.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 1.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.4 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 3.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.3 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.6 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 13.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.8 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.0 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0097617 | annealing activity(GO:0097617) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 32.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 9.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 15.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 7.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 15.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 10.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 9.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 3.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 7.9 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 3.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 15.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 3.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 2.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 2.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 7.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 2.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 11.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 3.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 6.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 6.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 8.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 2.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 13.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 5.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 5.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 5.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 6.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 10.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 11.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 7.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 4.9 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 2.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 4.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 2.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 2.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 4.6 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 7.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 2.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 5.4 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 4.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 3.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 14.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 21.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.2 | 16.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.2 | 14.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.2 | 12.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.1 | 2.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.0 | 9.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 0.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.9 | 4.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 0.7 | REACTOME S PHASE | Genes involved in S Phase |
0.7 | 1.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 4.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 5.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 7.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.6 | 10.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 5.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 17.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 5.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 5.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 13.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 1.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 13.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 4.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 5.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 5.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 4.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 4.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 8.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 6.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 7.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 9.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 2.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 6.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 5.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 5.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.4 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 6.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 6.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 10.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 37.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 3.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.4 | 14.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 7.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 6.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 4.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 10.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 5.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 4.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 5.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 5.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 15.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 1.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 10.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 2.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 2.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 4.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 2.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 7.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 8.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 7.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 1.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 8.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 2.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 1.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 3.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 3.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 9.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 5.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 4.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 11.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 4.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 3.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 2.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 2.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 4.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 1.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 3.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 13.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 4.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 8.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 8.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 3.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 14.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 4.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 12.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 3.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 1.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 3.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 3.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 10.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 7.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 2.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.6 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 3.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 3.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.3 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 6.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 2.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |